
|Videos|June 23, 2021
Dr. Ramasamy discusses clinical trial of nasal testosterone gel
Author(s)Urology Times staff
“It's quick to act and it's quick to leave the system,” says Ranjith Ramasamy, MD, of the nasal testosterone gel Natesto.
Advertisement
In this video, Ranjith Ramasamy, MD, discusses a clinical trial at his institution evaluating the nasal testosterone gel Nastesto. Ramasamy is an associate professor of urology and director of male reproductive medicine and surgery at the University of Miami Miller School of Medicine.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Beyond the clinic: Physician presence on social media
2
FDA updates in urology: December 2025
3
Daniel Spratt, MD, on using ArteraAI to guide salvage therapy decisions
4
Permanent J code for mitomycin for intravesical solution now in effect
5



















